DC Chemicals

All products / DC21257

LY2780301
CAT. NO. DC21257

LY2780301

Pack sizes and prices

Pack sizePrice
100 mg$700 USDRequest a quote / confirm availability →
250 mg$1,200 USDRequest a quote / confirm availability →
1 g$2,500 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

A potent, highly selective, ATP-competitive dual inhibitor of p70S6K and Akt under development for the treatment of solid tumours and non-Hodgkin's lymphoma; drastically decreases proliferation of hMECs with ErbB2-induced p70S6K activation via Cyclin B1 inhibition and cell cycle blockade at G0-G1 phase; exhibited antiproliferative activity in a broad range of cell lines using monolayer and colony formation assays, reduces proliferation of hMECs in vitro and ADH/MIN lesions in vivo.Breast CancerPhase 2 Clinical

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC21257
Product nameLY2780301
CAS1226801-23-5
Molecular formulaC25H27F4N7O
Molecular weight517.521798372269
Purity>98%
SMILESCN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3c2CC(=O)N3)CC1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — LY2780301 (DC21257)

Related research products

Browse newly added products